Loading insider details...
Beta
Latest Form 4 (Mar 4, 2026): Grant/Award of 25,873 EIKN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 4, 2026 | Eikon Therapeutics, Inc. (EIKN) | Grant/Award | 25,873 | n/a |
| Feb 6, 2026 | Eikon Therapeutics, Inc. (EIKN) | Purchase | 111,111 | $2.00M |
| Nov 8, 2022 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 235,769 | n/a |
| Nov 7, 2022 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 235,000 | n/a |
| Nov 3, 2022 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 300,000 | n/a |
| Nov 1, 2022 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 567,084 | n/a |
| Aug 19, 2022 | Merck & Co., Inc. (MRK) | Grant/Award | 28,532 | n/a |
| May 5, 2022 | Merck & Co., Inc. (MRK) | Grant/Award | 28,703 | n/a |
| Feb 28, 2022 | Merck & Co., Inc. (MRK) | Grant/Award | 119,488 | $8.78M |
| Jan 4, 2022 | EXXON MOBIL CORP (XOM) | Grant/Award | 2,500 | n/a |